National Center for Advancing and Translational Sciences Genetic and Rare Diseases Information Center, a program of the National Center for Advancing and Translational Sciences

Birt-Hogg-Dube syndrome



My husband is a survivor of chromophobe renal cell carcinoma (RCC). In addition, he has a lung hamartoma and bladder lipoma. Should genetic testing for Birt-Hogg-Dube syndrome (BHDS) be considered in light of his cancer history and other findings?

Birt-Hogg-Dube syndrome (BHDS) is a rare, complex, genetic disorder with three main clinical findings: non-cancerous (benign) skin tumors; lung cysts/history of pneumothorax; and various types of renal tumors. Chromophobe RCC is one of the more common types of renal tumors seen among patients with BHDS. Lipomas have been reported in patients with BHDS, albeit rarely. 

Due to your husband's RCC and lung cyst, a consultation with a genetics professional may be helpful for evaluation of BHDS. During this visit, a genetic counselor or medical geneticist will likely obtain a detailed medical and cancer history, and a comprehensive family history (in particular looking for other relatives with renal cancer or the other features of BHDS). If it seems that your husband's personal medical history and family history are suggestive of BHDS, then genetic testing for diagnosis of BHDS can be discussed. Genetic professionals have training and expertise in reviewing the risks, benefits, and limitations of genetic testing, ordering the appropriate genetic test, and interpreting the results. 

BHDS is caused by mutations in the FLCN gene. To date, FLCN is the only gene known to be associated with this syndrome. BHDS is inherited in an autosomal dominant manner. Some people with BHDS have an affected parent, and some have BHDS as the result of a new mutation in the FLCN gene that occurred around the time of conception (referred to as a "de novo" mutation).

Genetic testing of the FLCN gene identifies disease-causing mutations in most patients who have features consistent with BHDS. However, 7%-9% of patients who fulfill the clinical criteria for BHDS do not have an identifiable mutation in the FLCN gene. 

Genetics clinics are a source of information for individuals and families regarding genetic conditions, treatment, inheritance, and genetic risks to other family members. More information about finding and visiting a genetics professional is available from the Genetic Consultation Handbook developed by Genetics Home Reference. 

To find a genetics clinic, we recommend that you contact your primary healthcare provider for a referral. The following online resources can also help you find a genetics professional in your community:  


Last updated: 7/1/2015

We hope this information is helpful. We strongly recommend you discuss this information with your doctor. If you still have questions, please contact us.

Warm regards,
GARD Information Specialist

Please see our Disclaimer.


  1. Toro JR. Birt-Hogg-Dubé Syndrome. GeneReviews. 08/07/2014; http://www.ncbi.nlm.nih.gov/books/NBK1522/.